RARE DISEASERESEARCH ATLAS

ORPHA:1768

Familial caudal dysgenesis

low confidenceDisorder

Also known as: Rudd-Klimek syndrome

Publications

2,365

Trials

0

Interventional, condition-specific

Researchers

1,085

Distinct authors in sample

Gene link

VANGL1

Limited

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

A rare, genetic, developmental defect during embryogenesis disorder characterized by varying degrees of caudal dysgenesis, ranging from a single umbilical artery or imperforate anus to full sirenomelia, in several members of the same family. includes lumbosacral agenesis, anal atresia or ectopia, genitourinary abnormalities, components of VATER or VACTERL association, and facial dysmorphism (flat facies, abnormal ears, bilateral epicanthic folds, depressed nasal bridge, micrognathia). Additional features reported include cardiovascular (e.g. endocardial cushion defect, hypoplasia of pulmonary artery) and skeletal (kyphosis, hemipelvis) anomalies.

How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (2)

caudal regression · familial caudal dysgenesis

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.

  1. Gene identifiedPresent

    Limited — VANGL1

  2. LiteraturePresent

    2,365 matched papers (1,271 in last 10 years) Source

  3. Phenotype characterisedPresent

    30 HPO annotations (e.g. Rectal abscess; Myeloschisis; Absence of the sacrum) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Possibly — only limited evidence so far for VANGL1.

GenCC classification: Limited.

Phenotypes (Monarch / HPO)

30

Associated phenotypes · MONDO:0010831

  • Rectal abscess
  • Myeloschisis
  • Absence of the sacrum
  • Headache
  • Constipation

Showing 5 of 30 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

1 associated chemical · 9 pathways. Therapeutic evidence is listed first when present — not a treatment recommendation.

  • Tretinoin · marker/mechanism

Pathways: Wnt signaling pathway; Metabolism; Signal Transduction; Signalling by NGF; NGF processing; Chylomicron-mediated lipid transport; Lipoprotein metabolism; Metabolism of lipids and lipoproteins

MyDisease.info · MONDO:0010831

Literature

Is anyone studying this?

2,365

2,365 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

2,365 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

1,271 in the last 10 years · low confidence

Phrase hits: 1,092 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,085

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Gorter RR3 papers · 2026

    Department of Pediatric Surgery, Emma Children's Hospital Amsterdam UMC, Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.

    Papers in Europe PMC
  2. 02
    Sichitiu J3 papers · 2026

    Ultrasound and Fetal Medicine Unit, Woman-Mother-Child Department, University Hospital Center CHUV, Lausanne, Switzerland.

    Papers in Europe PMC
  3. 03
    Avelar-Gonzalez FJ2 papers · 2025

    Laboratory of Environmental Studies, Department of Physiology and Pharmacology, Basic Sciences Center, Autonomous University of Aguascalientes, Aguascalientes, Mexico.

    Papers in Europe PMC
  4. 04
    Bakker DP2 papers · 2026

    Amsterdam UMC, Department of Pediatric Neurology, Location University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.

    Papers in Europe PMC
  5. 05
    Ballardini E2 papers · 2026

    Department of Medical Sciences, Neonatal Intensive Care Unit, University Hospital of Ferrara, University of Ferrara, IMER Registry (Emilia Romagna Registry of Birth Defects), Ferrara, Italy.

    Papers in Europe PMC
  6. 06
    Barisic I2 papers · 2026

    Medical School University of Zagreb, Zagreb, Croatia.

    Papers in Europe PMC
  7. 07
    Bergman JEH2 papers · 2026

    Eurocat Northern Netherlands, Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

    Papers in Europe PMC
  8. 08
    Bouhmani B2 papers · 2026

    Réanimation Néonatale Et Pédiatrique, Néonatologie, CHU La Réunion, Saint Pierre, France.

    Papers in Europe PMC
  9. 09
    Bouhya S2 papers · 2024

    Maternity Service, Mother and Child Hospital Abderrahim Harouchi, University Hospital IBN ROCHD of Casablanca, Morocco; Gynecology Obstetric Department, Faculty of Medicine and Pharmacy of Casablanca, Hassan 2 University of Casablanca, Morocco; Biology and Health Laboratory (LBS), Hassan 2 University of Casablanca, Morocco.

    Papers in Europe PMC
  10. 10
    Chandra T2 papers · 2025

    Pediatric Radiology, Nemours Children's Hospital, Orlando, USA.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

low confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

General rare disease registries you may be eligible for

These studies enroll across many rare conditions. They are not counted as evidence that anyone is studying this specific disease.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-29

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Familial caudal dysgenesis — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("Familial caudal dysgenesis" OR "Rudd-Klimek syndrome" OR "caudal regression") OR ("VANGL1" OR "VANGL1 syndrome" OR "VANGL1-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Familial caudal dysgenesis" OR "Rudd-Klimek syndrome" OR "caudal regression"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • Publication count (2365) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity

Ingested 2026-07-26T18:05:49.664Z